The report provides market dynamics and trends related to the global antihypertensive drugs market. In addition, it presents the estimations and forecast of the market. It includes revenue generated from the sales of products such as diuretics, ACE inhibitors, calcium channel blockers, beta-adrenergic blockers, vasodilators, and others, which are provided by key players. For the purpose of analysis, the global antihypertensive drugs market is segmented into therapeutic class, distribution channel, and region. The study estimates the revenue generated from the sale of antihypertensive drugs through various distribution channel such as retail pharmacy, hospital pharmacy, and e-commerce websites & online drug stores. This further provides an understanding of the use of antihypertensive drugs. Moreover, the report covers the revenue generated from the sales of antihypertensive drugs offered in regions such as North America, Europe, Asia-Pacific, and LAMEA.

The global anti-acne serum market is analyzed on the basis of its prospects and future growth rate. The report highlights numerous factors that influence the growth of the global market. The report discusses the market forecast, drivers, restraints, opportunities, and role of different key players operating in the market. The report covers the revenue generated from the sale of anti-acne serum among males and females. Furthermore, it includes revenue generated from the anti-acne serum across North America, Europe, Asia-Pacific, and LAMEA.

The report provides market dynamics and trends related to the global anti-rheumatics market. In addition, it presents estimations and forecast of the market. It includes revenue generated from the sales of products such as disease modifying anti-rheumatics (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and others, which are provided by key players. For the purpose of analysis, the global anti-rheumatics market is segmented on the basis of drug class, type, and region. The study estimates the revenue generated from anti-rheumatics. By drug class, the market is divided into disease modifying anti-rheumatics (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and others. Moreover, for better understanding of the use of anti-rheumatics market, it is further divided by type into prescription-based drugs and over-the-counter drugs. In addition, the report covers revenue generated from the sales of anti-rheumatics in regions such as North America, Europe, Asia-Pacific, and LAMEA.

Allergy plays a significant role in patients with atopic dermatitis. The disease mostly flares up when the patient is around the things that cause allergic reactions. It is particularly common in infants and children, who are estimated to be about 10-20% having eczema, as mentioned under the American College of Allergy, Asthma & Immunology. There is a growing number of foundations, which are raising awareness regarding eczema and different types of dermatitis across various regions. The developed regions have a higher prevalence, as well as population, which is more active toward early detection of chronic autoimmune diseases. Thus, the role of rising campaigns each year is very important to fuel the growth of atopic dermatitis market. In March 2017, Sanofi and Regeneron Pharmaceuticals, Inc. announced US FDA approval of Dupixent (dupilumab) Injection. Following the approval, Dupixent was launched as a pre-filled syringe, which can be self- administered as a subcutaneous injection every other week after an initial loading dose. The high potency, long-lasting effect, and ease of administration have made Dupixent one of the most preferred form of Atopic dermatitis treatment method, however, the high annual cost of USD 37,000 can limit the adoption rates.

The Asia Pacific Cochlear Implants market is estimated to grow at a CAGR of 12.5% from 2018 - 2027. Key factors driving the market are rising number of elder population in Asia Pacific and increasing incidences of hearing loss in Asia Pacific. However, high cost associated with cochlear surgeries is anticipated to restrain the market growth in the forecast period. The top 10 industry players operating in the market of Cochlear Implants across the globe includes Cochlear Ltd., MED-EL, Sonova, Nurotron Biotechnology Co. Ltd., Medtronic, Demant A/S, Starkey, WIDEX A/S, Amplifon, and GN Hearing A/S. among the others..

Advancement in the field of patient simulators has enhanced the market. Many industry players have come up with innovative types of simulators in the last few years. The advancement in the simulators has led to faster and easier treatment and recovery of patients. Also, the investments from public and private investors are rising for the simulators. To improvise the technique, there have been various innovations as well as developments in the field. There have been numerous image enhancement innovations in recent years to enable better usage of simulators. New technologies were developed to reduce the time of the surgeons and the patients. For instance, in April 2017, Japanese researchers created a 3D printed robot to practice medical simulation. The robot named ‘Mikoto’, had realistic 3D printed organs, which provided a better realistic training simulation experience for medical students. The robot had initially been developed for three medical procedures: endotracheal intubation, gastrointestinal endoscopy and sputum suctioning. The robot is also equipped with various signals that sense pressure and pain and accordingly release signals and alert the practitioners. Thus, the innovative steps and technological advancements undertaken by new entrants as well as established market players to improve the quality and efficacy of patient simulators is expected to favour the growth of the market in the years to come..

Asthma in older adults has a notable impact on the elderly's quality of life. Asthma coincides with conditions such as obesity, decreased immunity, and chronic obstructive pulmonary disease (COPD), which are most common among this age population. Therefore, asthma can often be complicated and difficult to spot in the elderly and it often goes. Population Census 2011 stated that, there are nearly 104 million elderly population who are aged 60 years or above in India. Out of which 53 million are females and 51 million males. A report published by the United Nations Population Fund and HelpAge India states that the number of elderly persons is expected to grow to 173 million by 2026. Moreover, as per the National Center for Biotechnology Information (NCBI), China's elderly population is expanding more rapidly than the total population. The elderly population rose from 42 million in 1953 to 72 million in 1978. According to UN projection, China's elderly population will rise to 11% by the end of the century and 20% by 2025. The factors for the increase in the elderly population are a better standard of living and health care, a declining birth rate, longer life expectancy, and aging baby boom cohorts born in the last 30 years. Additionally, as per the Nippon Communications Foundation, In Tokyo, the total number of population aged over 75 will rise from 1.47 million in 2015 to 2.27 million in 2045.

In the mid-20th century, the advancement in cardiac surgery has created a need and demand for an artificial source that helps in stimulating the heart muscle. Initially, the scientist developed large-size external devices causing discomfort in patients. Later, the advancement in technology has resulted in the miniaturization of electronic circuitry and eventually the development of totally implantable devices. These advancements continue till date, with the recent introduction of leadless pacemakers, that are directly implanted within the cardiac chamber.

Heart failure is a chronic progressive condition that affects the pumping power of the heart muscles. Heart failure refers to a stage in which fluid builds up around the heart and makes it in-efficient in pumping. Humans have a four-chambered heart the upper half of the heart has two atria and the lower portion of the heart has two ventricles. The ventricles pump the blood to body organs, and tissues and atria receive the blood from the body to circulate the blood. There are two types of left ventricular failure, such as systolic heart failure and diastolic heart failure. The systolic heart failure is when the left ventricle fails to contract normally, whereas the diastolic dysfunction is when the heart muscle in the left ventricle becomes stiff.

Coronary artery disease (CAD) is the blockage or narrowing of the coronary arteries, that usually occurred by atherosclerosis. Atherosclerosis is the deposit of cholesterol and fatty matters, known as plaque on the inner walls of the arteries. Such buildup can restrict blood flow to the heart muscle by physically blocking the artery. Such a situation can cause chest pain which is called angina. Such cut off of blood supply to a portion of the heart muscle, may cause a heart attack.